{
     "PMID": "26189762",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160824",
     "LR": "20161126",
     "IS": "1873-7064 (Electronic) 0028-3908 (Linking)",
     "VI": "99",
     "DP": "2015 Dec",
     "TI": "Anti-stress effects of ONO-2952, a novel translocator protein 18 kDa antagonist, in rats.",
     "PG": "51-66",
     "LID": "10.1016/j.neuropharm.2015.07.011 [doi] S0028-3908(15)30017-4 [pii]",
     "AB": "Accumulating evidence has shown the pathophysiological significance of the translocator protein 18 kDa (TSPO) in the central nervous system. In this study, we evaluated the beneficial effects of ONO-2952, a novel TSPO antagonist in rat stress models. ONO-2952 potently bound both rat and human TSPO (Ki=0.330-9.30 nmol/L) with high selectivity over other receptors, transporters, ion channels and enzymes. ONO-2952 inhibited both neurosteroid accumulation and noradrenaline release in the brain of rats exposed to acute stress. The inhibitory effect of ONO-2952 on stress-induced noradrenaline release was attenuated by co-treatment with the TSPO agonist CB34 in a dose-dependent manner. ONO-2952, at 0.3 mg/kg or higher, dose-dependently suppressed restraint stress-induced defecation in rats with brain TSPO occupancy of more than 50%. In addition, ONO-2952, at 1 mg/kg or higher, suppressed conditioned fear stress-induced freezing behavior in rats with an efficacy equivalent to that of diazepam, given orally at 3 mg/kg. Results of the passive avoidance learning test revealed that ONO-2952, unlike diazepam, did not affect learning and memory even at doses 10 times higher than its effective doses in the stress models. The present findings indicate that ONO-2952 is a promising candidate for the treatment of stress-related disorders.",
     "CI": [
          "Copyright (c) 2015 Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Mitsui, Katsukuni",
          "Niwa, Tomohiro",
          "Kawahara, Yuji",
          "Morimoto, Noriko",
          "Ohmoto, Kazuyuki",
          "Kato, Masashi",
          "Yamaura, Yoshiyuki",
          "Yoshimoto, Naoki",
          "Suna, Hideaki",
          "Katsumata, Seishi"
     ],
     "AU": [
          "Mitsui K",
          "Niwa T",
          "Kawahara Y",
          "Morimoto N",
          "Ohmoto K",
          "Kato M",
          "Yamaura Y",
          "Yoshimoto N",
          "Suna H",
          "Katsumata S"
     ],
     "AD": "Discovery Research Laboratories I, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: ka.mitsui@ono.co.jp. Discovery Research Laboratories I, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: niwa@ono.co.jp. Discovery Research Laboratories I, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: kawahara@ono.co.jp. Discovery Research Laboratories I, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: no.morimoto@ono.co.jp. Medicinal Chemistry Research Laboratories, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: k.ohmoto@ono.co.jp. Medicinal Chemistry Research Laboratories, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: m.katou@ono.co.jp. Pharmaceutical Technology Laboratories, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: yamaura@ono.co.jp. Pharmacokinetic Research Laboratories, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: n.yoshimoto@ono.co.jp. Pharmacokinetic Research Laboratories, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: suna@ono.co.jp. Discovery Research Laboratories I, ONO Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan. Electronic address: s.katsumata@ono.co.jp.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150717",
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (Carrier Proteins)",
          "0 (Cyclopropanes)",
          "0 (Heterocyclic Compounds, 4 or More Rings)",
          "0 (ONO-2952)",
          "0 (Psychotropic Drugs)",
          "0 (Receptors, GABA)",
          "0 (Receptors, GABA-A)",
          "0 (TSPO protein, human)",
          "141440-82-6 (Tspo protein, rat)"
     ],
     "SB": "IM",
     "MH": [
          "Amygdala/drug effects/metabolism",
          "Animals",
          "Avoidance Learning/drug effects",
          "Carrier Proteins/antagonists & inhibitors/metabolism",
          "Cell Line, Tumor",
          "Cyclopropanes/chemistry/pharmacokinetics/*pharmacology",
          "Disease Models, Animal",
          "Dose-Response Relationship, Drug",
          "Drug Evaluation, Preclinical",
          "Freezing Reaction, Cataleptic/drug effects",
          "Heterocyclic Compounds, 4 or More Rings/chemistry/pharmacokinetics/*pharmacology",
          "Hippocampus/drug effects/metabolism",
          "Humans",
          "Male",
          "Psychotropic Drugs/chemistry/pharmacokinetics/*pharmacology",
          "Rats, Sprague-Dawley",
          "Rats, Wistar",
          "Receptors, GABA/metabolism",
          "Receptors, GABA-A/metabolism",
          "Restraint, Physical",
          "Stress, Psychological/*drug therapy/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Neurosteroid",
          "Noradrenaline",
          "ONO-2952",
          "Stress",
          "Translocator protein 18 kDa"
     ],
     "EDAT": "2015/07/21 06:00",
     "MHDA": "2016/08/25 06:00",
     "CRDT": [
          "2015/07/21 06:00"
     ],
     "PHST": [
          "2015/02/13 00:00 [received]",
          "2015/07/09 00:00 [revised]",
          "2015/07/11 00:00 [accepted]",
          "2015/07/21 06:00 [entrez]",
          "2015/07/21 06:00 [pubmed]",
          "2016/08/25 06:00 [medline]"
     ],
     "AID": [
          "S0028-3908(15)30017-4 [pii]",
          "10.1016/j.neuropharm.2015.07.011 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 2015 Dec;99:51-66. doi: 10.1016/j.neuropharm.2015.07.011. Epub 2015 Jul 17.",
     "term": "hippocampus"
}